Dr. LeBeaut joined I-ACT for Children in May 2021. He is a pediatrician with extensive global research and development expertise, including more than 25 years in the biopharmaceutical industry.
Dr. LeBeaut most recently served as executive vice president of research and development and chief scientific officer at IPSEN Bioscience in Cambridge, Massachusetts. His distinguished career in global drug development includes senior leadership roles at Bluebird Bio, Axcan Pharmaceuticals, Sanofi, Novartis and Schering-Plough Research Institute. He has helped develop and successfully bring to patients therapeutic solutions in oncology, infectious diseases, pediatrics, genetic diseases, gastroenterology, cardio-metabolic and neurological disorders.
Dr. LeBeaut received his M.D. from Paris Diderot University in France and trained in Pediatrics at Paris Descartes University. He began his career as a resident fellow in general pediatric and intensive care units in Paris.